Lisa M. Giles

Insider Reports History

Location
Chicago, IL
Signature
/s/ Jason Minio, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lisa M. Giles:

Company Role Class Num Shares Value Price $ Report Date Ownership
HCW Biologics Inc. Director Common Stock 35,815 $50,141 $1.40 20 Feb 2024 Direct
Milestone Pharmaceuticals Inc. Director Stock Option (right to buy) 40,000 10 Jun 2025 Direct
HCW Biologics Inc. Director Stock Option (Right to Buy) 12,500 14 Jun 2024 Direct

Insider Reports Filed by Lisa M. Giles

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MIST Milestone Pharmaceuticals Inc. 10 Jun 2025 1 $0 4 Director 12 Jun 2025, 16:19
MIST Milestone Pharmaceuticals Inc. 28 Aug 2024 1 $0 4 Director 29 Aug 2024, 16:15
HCWB HCW Biologics Inc. 14 Jun 2024 1 $0 4 Director 17 Jun 2024, 17:07
HCWB HCW Biologics Inc. 20 Feb 2024 1 +$50,001 4 Director 22 Feb 2024, 14:22
HCWB HCW Biologics Inc. 13 Jun 2023 1 $0 4 Director 15 Jun 2023, 17:13
MIST Milestone Pharmaceuticals Inc. 07 Jun 2023 1 $0 4 Director 09 Jun 2023, 16:21
MIST Milestone Pharmaceuticals Inc. 05 Jul 2022 1 $0 4 Director 11 Aug 2022, 18:01
HCWB HCW Biologics Inc. 15 Jun 2022 1 $0 4 Director 17 Jun 2022, 16:18
HCWB HCW Biologics Inc. 26 Oct 2021 1 $0 4 Director 28 Oct 2021, 17:12
HCWB HCW Biologics Inc. 26 Oct 2021 0 $0 3 Director 28 Oct 2021, 17:04
MIST Milestone Pharmaceuticals Inc. 14 Jun 2021 1 $0 4 Director 29 Jul 2021, 17:35